Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Professor Penny Lovat
Newcastle Authors
Title
Year
Full text
Dr Tom Andrew
Professor Ruth Plummer
Professor Nick Reynolds
Guin Brownell
Professor Penny Lovat
et al.
A hybrid machine learning approach for the personalized prognostication of aggressive skin cancers
2025
Dr Tom Andrew
Professor Ruth Plummer
Professor Penny Lovat
Aidan Rose
A multivariable disease-specific model enhances prognostication beyond current Merkel cell carcinoma staging: An international cohort study of 10,958 patients
2025
Dr Tom Andrew
Grant Richardson
Professor Philip Sloan
Professor Ruth Plummer
Professor Penny Lovat
Multimodal AI and tumour microenvironment integration predicts metastasis in cutaneous melanoma
2025
Dr Jing Xuan Lim
Tegan McTaggart
Dr Katie Smith
Dr Gill Hulme
Dr Stephanie Laba
et al.
PD-1 receptor deficiency enhances CD30
+
T
reg
cell function in melanoma
2025
Professor Penny Lovat
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma
2024
Dr Krishan Mistry
Grant Richardson
Rob Smith
Professor Penny Lovat
Porcine-derived collagen peptides promote re-epithelialisation through activation of integrin signalling
2024
Moyassar Al-Shaibani
Dr Xiao Wang
Dr Asif Tulah
Dr Rachel Crossland
Professor Anne Dickinson
et al.
Role of mesenchymal stem cell conditioned medium on wound healing using a developed 3D skin model
2024
George Kelly
Dr Tetsushi Kataura
Dr Johan Panek
Hanna Salmonowicz
Hannah Kendall
et al.
Suppressed basal mitophagy drives cellular aging phenotypes that can be reversed by a p62-targeting small molecule
2024
Michael Alexander
Will Cousins
Dr Tom Ewen
Professor Penny Lovat
The combined immunohistochemical expression of AMBRA1 and SQSTM1 identifies patients with poorly differentiated cutaneous squamous cell carcinoma at risk of metastasis: A proof of concept study
2024
Dr Tom Ewen
Stuart Horswell
Dr Helen Bosomworth
Joe Lowenstein
Grant Richardson
et al.
Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma
2024
Dr Ioana Cosgarea
Dr Roisin Stout
Dr Katie Best
Professor Penny Lovat
Endothelial AMBRA1 and Claudin5 as potential biomarkers of metastases in early-stage melanoma
2023
Patience Kunonga
Dr Ryan Kenny
Margaret Astin
Andrew Bryant
Vasileios Kontogiannis
et al.
Predictive accuracy of risk prediction models for recurrence, metastasis and survival for early-stage cutaneous melanoma: a systematic review
2023
Dr Jing Xuan Lim
Grace Mallett
Dr David McDonald
Dr Gill Hulme
Dr Stephanie Laba
et al.
Programmed cell death-1 receptor-mediated regulation of Tbet
+
NK1.1
-
innate lymphoid cells within the tumor microenvironment
2023
Dr Francesco Zummo
Merilin Georgiou
Kirsty Cullen
Minna Honkanen-Scott
Professor James Shaw
et al.
Exendin-4 stimulates autophagy in pancreatic β-cells via the RAPGEF/EPAC-Ca2+-PPP3/calcineurin-TFEB axis
2022
Jan Lecouturier
Dr Helen Bosomworth
Dr Marie Labus
Dr Robert Ellis
Professor Penny Lovat
Health professional and patient views of a novel prognostic test for melanoma: A theoretically informed qualitative study
2022
1
2
3
4
5
6
7
8
9